Last week saw a large number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.
Here's why brokers think investors ought to buy them next week:
Appen Ltd (ASX: APX)
According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating and lifted the price target on this artificial intelligence services company's shares to $43.00. Although Macquarie acknowledges that Appen's first half performance was softer than the market expected, it still believes it will achieve its guidance in FY 2020. It also remains very positive on the future thanks to the increasing spending on artificial intelligence. I agree with Macquarie on Appen and feel it would be a great buy and hold option.
Aventus Group (ASX: AVN)
Analysts at UBS have upgraded this property company's shares to a buy rating and lifted the price target on them to $2.50. According to the note, the broker was impressed with Aventus' FY 2020 results and believes it demonstrates the strength of its large format retail assets. And while it acknowledges that no guidance was given for the year ahead, it remains positive on its outlook and expects its assets to benefit from changing consumer habits. I think UBS is spot on and would be a buyer of Aventus' shares.
Bravura Solutions Ltd (ASX: BVS)
Another note out of Macquarie reveals that its analysts have retained their outperform rating but trimmed the price target on this financial technology company's shares to $5.50. Although Bravura's performance in FY 2021 looks set to be disrupted by the pandemic, the broker appears confident this is temporary and its long term prospects remain positive. In light of this, it feels it is worth sticking with the company. I agree with Macquarie and would buy and hold Bravura shares.
